Axsome Therapeutics Inc (AXSM) — Quality & forensics
As of 2026-10-29 — refreshed nightly. Closelooknet readings from an investment research diary, not ratings or advice.
The Closelooknet module scores
- Valuation 13
- Quality 23
- Growth 72
- Balance sheet 42
- Cash quality 51
- Capital allocation 13
- Momentum 14
Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.
Financial forensics — the academic screens
Sits in the safe zone (above 2.99). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.
Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.
Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.
Continue: the AXSM chart & overview · the earnings record
FAQ · from the current data · as of 2026-10-29
Quick answers
What is Axsome Therapeutics Inc's Closelooknet quality reading?
The composite reads 35/100 across 7 modules, as of 2026-10-29: valuation 13, quality 23, growth 72, balance sheet 42, cash quality 51, capital allocation 13, momentum 14. Closelooknet scores are research diary readings, not ratings or investment advice.
What is Axsome Therapeutics Inc's Altman Z-Score?
5.41, which sits in the safe zone (above 2.99) as of 2026-10-29. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.
What is Axsome Therapeutics Inc's Piotroski F-Score?
5 of 9, as of 2026-10-29. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.
What does Axsome Therapeutics Inc's Beneish M-Score indicate?
-2.57 — below the −1.78 manipulation-risk threshold, as of 2026-10-29. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- BION.SW BB Biotech AGindustry
- HALO Halozyme Therapeutics Incindustry
- UCB.BR UCB SAindustry
- ARGX.BR Argen-Xindustry
- ARGX argenx NV ADRindustry
- RIGL Rigel Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- REPL Replimune Group Incindustry
- ABSI Absci Corpindustry
- MRNA Moderna Incindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- BHVN Biohaven Ltd.industry
- ARQT Arcutis Biotherapeutics Incindustry
- ADMA ADMA Biologics Incindustry
- MAZE Maze Therapeutics, Inc. Common Stockindustry
- SEPN Septerna, Inc. Common Stockindustry
- IRON Disc Medicine Inc.industry
- RXRX Recursion Pharmaceuticals Incindustry
- ALK-B.CO ALK-Abelló A/Sindustry